Search Within

Heiko Schoder

  1. "Survivorship Research"
Formats
  1. Journal Article (76)
  2. Meeting Abstract (66)
  3. Research Letter (3)
  4. Conference Paper (1)
  5. Editorial (1)
Groups
  1. Molecular Imaging and Therapy Service (147)
  2. Radiology, Department of (147)
  3. Survivorship Research (147)
  4. Department of Medicine (122)
  5. Radiation Oncology, Department of (86)
  6. Center for Hematologic Malignancies (81)

More Groups

People
  1. Joachim Yahalom (50)
  2. Andrew Zelenetz (48)
  3. Maria Palomba (48)
  4. Paul Hamlin (46)
  5. Alison Moskowitz (45)
  6. Anita Kumar (43)

More People

Years
  1. 2025 (5)
  2. 2024 (13)
  3. 2023 (18)
  4. 2022 (9)
  5. 2021 (16)
  6. 2020 (12)

More Years

Publications
  1. Blood (29)
  2. Journal of Clinical Oncology (21)
  3. International Journal of Radiation Oncology, Biology, Physics (18)
  4. Journal of Nuclear Medicine (10)
  5. Hematological Oncology (9)
  6. Cancer (4)

More Publications

Publishers
  1. American Society of Hematology (31)
  2. Elsevier Inc. (22)
  3. American Society of Clinical Oncology (21)
  4. Wiley Blackwell (13)
  5. Society of Nuclear Medicine (10)
  6. Springer (9)

More Publishers

Results (147)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T‐cell therapy outcome
    Meeting Abstract

    Imber, B. S.; Silverman, E. A.; Leithner, D.; Hubbeling, H.; Shah, G. L.; Fregonese, B.; Sanin, B. W.; Tomas, A. A.; Parascondola, A.; Saldia, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Bridging radiation rapidly and effectively cytoreduces high-risk relapsed/refractory aggressive B cell lymphomas prior to chimeric antigen receptor T cell therapy
    Journal Article

    Hubbeling, H.; Silverman, E. A.; Michaud, L.; Tomas, A. A.; Shouval, R.; Flynn, J.; Devlin, S.; Wijetunga, N. A.; Tringale, K. R.; Batlevi, C.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity
    Journal Article

    Yu, Y.; Schöder, H.; Zakeri, K.; Chen, L.; Kang, J. J.; McBride, S. M.; Tsai, C. J.; Gelblum, D. Y.; Boyle, J. O.; Cracchiolo, J. R.; more...
    Oral Oncology (2023)

    Fulltext@MSK | Save
  • Outcomes of patients with positive interim positron emission tomography (PET) continuing ABVD in the clinical setting
    Journal Article

    Zheng, S.; Gupta, K.; Goyal, P.; Nakajima, R.; Michaud, L.; Batlevi, C. L.; Hamlin, P. A.; Horwitz, S.; Kumar, A.; Matasar, M. J.; more...
    Cancers (2023)

    Fulltext@MSK | Save
  • Polyethylene glycol 3350 (PEG 3350) as a practical vehicle for rapid reconstitution of PARPi-FL formulations for clinical use
    Journal Article

    de Souza França, P. D.; Viray, T.; Roberts, S.; Michel, A.; Abrahão, M.; Patel, S. G.; Ganly, I.; Schöder, H.; Brand, C.; Reiner, T.; more...
    Molecular Imaging and Biology (2023)

    Fulltext@MSK | Save
  • Long-term outcomes of patients with limited-stage ocular adnexal DLBCL treated with combined modality therapy in the rituximab era
    Research Letter

    Qualls, D.; Imber, B. S.; Okwali, M.; Hamlin, P. A.; Kumar, A.; Lahoud, O. B.; Matasar, M. J.; Noy, A.; Owens, C.; Zelenetz, A. D.; more...
    British Journal of Haematology (2023)

    Fulltext@MSK | Save
  • Immune signature of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Ganesan, N.; Shah, G. L.; Wong, P.; Argyropoulos, K. V.; Sen, F.; Dogan, A.; Straus, D. J.; Noy, A.; Kumar, A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Correlative biomarkers for CART19 response in patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Batlevi, C. L.; Nos, G.; Kotlov, N.; Sorokina, M.; Okwali, M.; Bagaev, A.; Michaud, L.; Shah, G. L.; Shouval, R.; Tomas, A. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Brentuximab vedotin combined with chemotherapy in newly diagnosed, early-stage, unfavorable-risk Hodgkin lymphoma: Extended follow-up with evaluation of baseline metabolic tumor volume and PET2
    Meeting Abstract

    Stuver, R.; Michaud, L.; Casulo, C.; Advani, R. H.; Budde, E. L.; Barr, P. M.; Batlevi, C. L.; Caron, P. C.; Constine, L. S.; Dandapani, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Failure patterns by PSMA PET for recurrent prostate cancer after prostatectomy and salvage radiation
    Journal Article

    Imber, B. S.; O'Dwyer, E.; Lobaugh, S.; McBride, S. M.; Hopkins, M.; Kollmeier, M.; Gorovets, D.; Brennan, V.; Pike, L. R. G.; Gewanter, R.; more...
    Urology (2022)

    Fulltext@MSK | Save